Isogenica Overview

  • Year Founded
  • 1998

Year Founded

  • Status
  • Private

  • Employees
  • 23

Employees

  • Latest Deal Type
  • Grant

  • Latest Deal Amount
  • $157K

  • Investors
  • 3

Isogenica General Information

Description

Developer of versatile small-format antibodies designed to construct biotherapeutics for the treatment of cancer, inflammation, and other serious diseases. The company's antibodies can be assembled to create bispecific and multi-specific biotherapeutics or used to achieve targeted drug delivery as components of ADCs, cell and gene therapies, enabling medical research centers to provide a powerful discovery engine for single-domain biotherapeutics.

Contact Information

Formerly Known As
Pharmacophorix
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • The Mansion House
  • Chesterford Research Park, Little Chesterford
  • Essex CB10 1XL
  • England, United Kingdom
+44 01799
Primary Industry
Drug Discovery
Other Industries
Biotechnology
Corporate Office
  • The Mansion House
  • Chesterford Research Park, Little Chesterford
  • Essex CB10 1XL
  • England, United Kingdom
+44 01799

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Isogenica Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
6. Grant 01-Oct-2021 $157K Completed Generating Revenue
5. Later Stage VC 24-Oct-2016 Completed Generating Revenue
4. Later Stage VC 30-Jun-2014 Completed Generating Revenue
3. Later Stage VC 29-Nov-2012 Completed Generating Revenue
2. Grant 08-May-2012 $9.2M $3.96M Completed Generating Revenue
1. Later Stage VC 06-May-2008 $3.96M $3.96M Completed Generating Revenue
To view Isogenica’s complete valuation and funding history, request access »

Isogenica Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate (%) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion Price % Owned
Ordinary .6
Ordinary .747
To view Isogenica’s complete cap table history, request access »

Isogenica Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Developer of versatile small-format antibodies designed to construct biotherapeutics for the treatment of cancer, inflam
Drug Discovery
Essex, United Kingdom
23 As of 2026

Bangalore, India
 

Bengaluru, India
 
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Isogenica Competitors (4)

One of Isogenica’s 4 competitors is Strand (Biotechnology), a Formerly VC-backed company based in Bangalore, India.

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Strand (Biotechnology) Formerly VC-backed Bangalore, India
Genotypic Technology Corporation Bengaluru, India
Isomerase Formerly VC-backed Cambridge, United Kingdom
Vicore Pharma Holding Formerly VC-backed Stockholm, Sweden
To view Isogenica’s complete competitors history, request access »

Isogenica Patents

Isogenica Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
GB-202312183-D0 Single domain antibodies Inactive 09-Aug-2023
GB-202215365-D0 Single domain antibodies Pending 18-Oct-2022
WO-2024084203-A1 Single domain antibodies binding to albumin Inactive 18-Oct-2022
WO-2020080941-A1 Anti- low-density lipoprotein receptor-related protein 5/6 antibodies Inactive 16-Oct-2018
GB-2500243-A Identifying members of immobilised peptide libraries comprising protein-dna complexes Inactive 15-Mar-2012 C12N15/1034
To view Isogenica’s complete patent history, request access »

Isogenica Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Isogenica Investors (3)

Investor Name Investor Type Holding Investor Since Participating Rounds
Innovate UK Government Minority
Horizon 2020 Government
KC Holding Corporation Minority
To view Isogenica’s complete investors history, request access »

Isogenica FAQs

  • When was Isogenica founded?

    Isogenica was founded in 1998.

  • Where is Isogenica headquartered?

    Isogenica is headquartered in Essex, United Kingdom.

  • What is the size of Isogenica?

    Isogenica has 23 total employees.

  • What industry is Isogenica in?

    Isogenica’s primary industry is Drug Discovery.

  • Is Isogenica a private or public company?

    Isogenica is a Private company.

  • What is Isogenica’s current revenue?

    The current revenue for Isogenica is .

  • How much funding has Isogenica raised over time?

    Isogenica has raised $6.35M.

  • Who are Isogenica’s investors?

    Innovate UK, Horizon 2020, and KC Holding have invested in Isogenica.

  • Who are Isogenica’s competitors?

    Strand (Biotechnology), Genotypic Technology, Isomerase, and Vicore Pharma Holding are competitors of Isogenica.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process